Question

A 64-year-old man with type 2 diabetes, BMI 31 kg/m2, hypertension and established coronary artery disease has HbA1c 7.8% (62 mmol/mol) on maximised metformin. Renal function is eGFR 55 mL/min/1.73 m2. What additional glucose-lowering medication is preferred to reduce cardiovascular risk?

Accepted Answer

SGLT2 inhibitor such as empagliflozin

Answer

Sulfonylurea such as gliclazide

Answer

DPP-4 inhibitor such as sitagliptin

Answer

Thiazolidinedione such as pioglitazone

Answer

Basal insulin

Practice question

A 64-year-old man with type 2 diabetes, BMI 31 kg/m2, hypertension and established coronary artery disease has HbA1c 7.8% (62 mmol/mol) on maximised metformin. Renal function is eGFR 55 mL/min/1.73 m2. What additional glucose-lowering medication is preferred to reduce cardiovascular risk?